Tibet Rhodiola Pharmaceutical Holding Co.
Shanghai Stock Exchange 600211.SS
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.46
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share is USD 0.46 for the year ending December 31, 2023, a 5.90% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
-
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share for the year ending December 31, 2022 was USD 0.43, a 1,246.77% change year over year.
-
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.04, a -129.32% change year over year.
-
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.13, a -49.52% change year over year.
-
Tibet Rhodiola Pharmaceutical Holding Co. Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.25, a 64.73% change year over year.
Key data
| Date | Free Cash Flow Per Share | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
|---|
Market news
Loading...
Shanghai Stock Exchange: 600211.SS
| CEO | Mr. Yuan Dong Guo |
| IPO Date | July 21, 1999 |
| Location | China |
| Headquarters | No. 93, Beijing Middle Road |
| Employees | 601 |
| Sector | Health Care |
| Industries | |
Description
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email